SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010977
Filing Date
2021-08-09
Accepted
2021-08-09 16:14:41
Documents
77
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20210630x10q.htm   iXBRL 10-Q 2161475
2 EX-31.1 cara-20210630xex31d1.htm EX-31.1 12111
3 EX-31.2 cara-20210630xex31d2.htm EX-31.2 11784
4 EX-32.1 cara-20210630xex32d1.htm EX-32.1 10158
  Complete submission text file 0001558370-21-010977.txt   9162511

Data Files

Seq Description Document Type Size
5 EX-101.SCH cara-20210630.xsd EX-101.SCH 57265
6 EX-101.CAL cara-20210630_cal.xml EX-101.CAL 58219
7 EX-101.DEF cara-20210630_def.xml EX-101.DEF 260353
8 EX-101.LAB cara-20210630_lab.xml EX-101.LAB 526488
9 EX-101.PRE cara-20210630_pre.xml EX-101.PRE 434479
10 EXTRACTED XBRL INSTANCE DOCUMENT cara-20210630x10q_htm.xml XML 1841140
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 211156660
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences